Objective: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is currently a pandemic. Although pulmonary health …

Prevalence of dermatological manifestations of coronavirus disease 2019 (COVID‐19) is
estimated between 0.25% and 3% in children and adolescents. In this review article, we …

Background Acral lesions, mainly chilblains, are the most frequently reported cutaneous
lesions associated with COVID‐19. In more than 80% of patients tested, nasopharyngeal …

Abstract Purpose of Review At the juncture of the COVID-19 pandemic, the world is currently
in an early phase of collecting clinical data and reports of its skin manifestations, and its …

The COVID-19 has affected worldwide population at every level from advance to under
developed countries and also majorly affected clinical microbiology labs. This critique …

At the end of December 2019, a new coronavirus denominated Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) was identified in Wuhan, Hubei province, China …

During the coronavirus disease 2019 (COVID-19) pandemic, people of all ages are
susceptive to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Objective: The aim of this study was to evaluate the coronavirus disease 2019 (COVID-19)
cutaneous manifestations described in pediatric patients and discuss their relevance for …

ABSTRACT COVID-19 began in December 2019 in Wuhan City, China, and on March 11,
2020 it was classified by the World Health Organization as a pandemic. It is an …

Cutaneous manifestation of COVID 19 in children has not yet been reviewed systematically.
Hence, this review gives the clinicians a future direction to be vigilant for skin presentations …